Restart Life Sciences Corp. Stock Price

CNSX:HEAL Community·CA$3.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

HEAL Share Price Performance

CA$0.095

0.04 (90.00%)

CA$0.095

0.04 (90.00%)

CA$0.095

Tue, 21 Oct 25

Share PriceCA$0.095

HEAL Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks

1 Reward

View Full Analysis

Restart Life Sciences Corp. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.016
: 0%
: 0%
: 0%

View Full Analysis

About HEAL

Founded: 2004
Employees: n/a
CEO: Steve Loutskou
WebsiteView website: www.restartlife.co

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.